Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
40.79
+0.14 (0.34%)
At close: Apr 10, 2026, 4:00 PM EDT
40.77
-0.02 (-0.05%)
After-hours: Apr 10, 2026, 6:47 PM EDT
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $5.21 billion as of April 10, 2026. Its market cap has increased by 74.64% in one year.
Market Cap
5.21B
Enterprise Value
5.22B
1-Year Change
74.64%
Ranking
Category
Stock Price
$40.79
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.10M to $5.21B, an increase of 654.54%. That is a compound annual growth rate of 27.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 5.21B | 64.06% |
| Dec 31, 2025 | 3.18B | -19.93% |
| Dec 31, 2024 | 3.97B | -44.04% |
| Dec 29, 2023 | 7.09B | 24.06% |
| Dec 30, 2022 | 5.72B | 38.54% |
| Dec 31, 2021 | 4.13B | -4.73% |
| Dec 31, 2020 | 4.33B | 121.45% |
| Dec 31, 2019 | 1.96B | 163.72% |
| Dec 31, 2018 | 741.80M | -32.09% |
| Dec 29, 2017 | 1.09B | 58.05% |
| Nov 9, 2017 | 691.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scholar Rock Holding | 5.74B |
| CG Oncology | 5.72B |
| PTC Therapeutics | 5.69B |
| Celcuity | 5.66B |
| Xenon Pharmaceuticals | 5.57B |
| Erasca | 5.29B |
| Caris Life Sciences | 5.10B |
| Immunovant | 4.99B |